EU Council’s Authorized Rep Liability Demands: Counter-Arguments, Alternatives, And Threat To TTIP
This article was originally published in Clinica
Fundamental legal anomalies are being identified that could shake the basis of proposals made by the Council of European Union to make authorized representatives fully liable for defective devices. These proposals, as they are, would mean that authorized representatives have to take up prohibitively expensive liability insurance in future to represent medical device and IVD manufacturers that do not have a base in the EU.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.